Our Take
The plateau at 120 minutes per week is the real finding—more training adds no measurable survival benefit, which contradicts the 'more is better' fitness narrative.
Why it matters
This cohort study reframes strength training as a dose-dependent mortality intervention, not a vanity metric. Anyone designing corporate wellness programs or personal fitness routines now has a specific, evidence-backed ceiling.
Do this week
Health officers: audit your corporate fitness incentives this quarter to ensure they reward 90-120 min/week of resistance work, not arbitrary volume targets above that threshold.
30-year cohort confirms strength training dose-response on mortality
Researchers tracked 147,374 health professionals over three decades (1992–2022), recording resistance training exposure and all-cause mortality outcomes. During the follow-up period, 35,798 participants died. The study, published in the British Journal of Sports Medicine, quantified the protective effect of strength training against death in three categories: all-cause, cardiovascular, and neurological.
The headline finding: 90–119 minutes per week of resistance training correlated with a 13% lower risk of all-cause mortality, compared with no resistance training (adjusted for aerobic activity). The same dose cut cardiovascular mortality risk by 19% and neurological disease mortality by 27%. Critically, no further benefit accrued beyond 120 minutes per week.
When combined with aerobic exercise, the effect multiplied. Participants performing more than 45 MET hours per week of aerobic activity (roughly 150+ minutes of moderate-intensity cardio) alongside 60–119 minutes of strength training showed a 53–58% lower mortality risk. Aerobic activity alone, at any level above 7.5 MET hours per week, reduced death risk by 26–43%.
The dose ceiling rewrites the fitness prescription
Conventional fitness guidance emphasizes volume accumulation. This study introduces a hard boundary: more strength training beyond 120 minutes weekly offers no measurable survival advantage. That changes the cost-benefit calculus for anyone allocating time, money, or program design to resistance work.
The researchers noted that while aerobic exercise's mortality benefit is well-established in literature, resistance training's independent role has been unclear. This 30-year prospective design (using repeated measures across decades) provides the strongest evidence to date that muscle-strengthening activity operates as a distinct protective mechanism, independent of cardio.
The implication is practical: you do not need to be a gym devotee to capture the mortality benefit. Ninety minutes per week is achievable for most working adults and delivers the full dose-response effect. This contradicts the implicit message of many fitness products and influencer campaigns, which normalize 5–6 hour weekly training commitments as standard.
Design wellness interventions around the 90-minute floor, not the sky
Corporate wellness programs and public health bodies now have a specific evidence-based target. Incentivize 90–120 minutes of resistance training weekly, not arbitrary volume beyond that. Pair it with 150+ minutes of moderate-intensity aerobic work to maximize the mortality reduction (53–58% vs. 13% for strength training alone).
For occupational health teams: stop framing exercise as an unlimited accumulation game. Market the 90-minute minimum as sufficient and achievable, which will improve participation rates and sustainability. The data removes the implicit guilt of "not doing enough" once you hit the threshold.
Limitations to note: the cohort was predominantly white, male, and health-educated (Health Professionals Follow-up Study), so generalizability to other populations is unknown. The study is observational, not randomized, so causality is inferred but not proven. However, the consistency of the dose-response curve and the magnitude of effect (per peer-reviewed publication in a top-tier journal) make this a credible baseline for program design.